Announcement PDF ASX ANNOUNCEMENT Appendix 3Y – Natalie Butler 21 September 2026, Melbourne: Elixinol Wellness Limited (ASX: EXL) (“EXL”, “Elixinol” or the Company) wishes to advise that the attached Appendix 3Y – Change of Director’s Interest Notice for NatalieButlerhas been lodged outsidethetimeframe required under ASXListing Rule3.19A.2. The change in holdings resulted from a small parcel of shares held by Ms. Butler being sold pursuant to the completion of the Small Parcel Sale Facility announced by the Company on 18 June 2026. The late lodgement was due to an administrative oversight. EXL acknowledges its obligations under the ASX Listing Rules and has taken steps to strengthen its internal processes to ensure timely compliance with the relevant disclosure requirements. Authorised for release by the Board of Elixinol Wellness Limited. For further information, please contact: Natalie Butler, CEO & Executive Director natalie.butler@elixinolwellness.com About Elixinol Wellness Elixinol Wellness Limited (ASX: EXL) is a sustainable nutrition and wellness company operating across Australia and the USA. The Company produces, manufactures, and distributes a range of complementary products spanning key verticals including nutrition, wellness, and superfood ingredients. In Australia, Elixinol Wellness operates a vertically integrated hemp foods business. Its major retail brands include The Healthy Chef, Hemp Foods Australia and Mt Elephant, alongside ingredient brands Australian Primary Hemp and The Australian Superfood Co. Products are sold through grocery, wholesale, and e-commerce channels. To find out more, please visit www.elixinolwellness.com or the Elixinol Wellness Investor Hub. Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Elixinol Wellness Limited ABN 34 621 479 794 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Natalie Butler Date of last notice 16 July 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Denereaz Holdings Pty Ltd (Ms Butler is a director and beneficiary) Date of change 18 June 2026 No. of securities held prior to change Direct: 36,417 Performance Rights 36,417 Fully Paid Ordinary Shares Indirect: 144,329 Fully Paid Ordinary Shares Class Fully Paid Ordinary Shares Number acquired Nil Number disposed 36,417 Fully Paid Ordinary Shares Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Approximately $0.006 per share as part of the Small Parcel Sale Facility. No. of securities held after change Direct: 36,417 Performance Rights Indirect: 144,329 Fully Paid Ordinary Shares Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back Fully Paid Ordinary Shares were disposed as part of the completion of the Small Parcel Sale Facility as announced by the Company on 18 June 2026. Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A